Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Hudson Bay Capital Management LP DPCS DP Cap Acquisition Corp I Class A Ordinary Shares 13G 9.85% 2y
Allred Aaron R UPBD Upbound Group, Inc. 13G/A 9.4% 2y
COWEN AND COMPANY, LLC LCAA L Catterton Asia Acquisition Corp Class A Ordinary Shares 13G/A 3.24% 2y
Cowen Financial Products LLC AGAC African Gold Acquisition Corporation 13G/A 0% 2y
COWEN AND COMPANY, LLC AFJK Aimei Health Technology Co., Ltd. 13G 5.3% 2y
Cowen Financial Products LLC JNCE Jounce Therapeutics, Inc. Common Stock 13G/A 0% 2y
COWEN AND COMPANY, LLC TRCA Twin Ridge Capital Acquisition Corp. 13G/A 0% 2y
COWEN AND COMPANY, LLC AOGO Arogo Capital Acquisition Corp. Class A Common Stock 13G 7.1% 2y
COWEN AND COMPANY, LLC JWSMF Jaws Mustang Acquisition Corp 13G 5.9% 2y
Cowen Financial Products LLC SLVM Sylvamo Corp 13G/A 0% 2y
Cowen Financial Products LLC SCPH scPharmaceuticals Inc. Common Stock 13G/A 0% 2y
WESTFIELD CAPITAL MANAGEMENT CO LP ASND Ascendis Pharma A/S 13G/A 7.05% 2y
GOLDMAN SACHS GROUP INC BATL Battalion Oil Corp 13G/A 4% 2y
COWEN AND COMPANY, LLC LGAC Lazard Growth Acquisition Corp. I Ordinary Shares 13G/A 0% 2y
COWEN AND COMPANY, LLC KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares 13G 5.8% 2y
COWEN AND COMPANY, LLC ANSC Agriculture & Natural Solutions Acquisition Corp 13G 6.2% 2y
Cowen Financial Products LLC CWLXF C21 Investments Inc. 13G/A 0% 2y
Cowen Financial Products LLC TARS Tarsus Pharmaceuticals, Inc. 13G/A 5.77% 2y
COWEN AND COMPANY, LLC CNDA Concord Acquisition Corp II 13G 5.5% 2y
COWEN AND COMPANY, LLC KCGI Kensington Capital Acquisition Corp. V 13G 6.6% 2y
COWEN AND COMPANY, LLC PRIAF Prime Impact Acquisition I 13G/A 0% 2y
COWEN AND COMPANY, LLC GLST Global Star Acquisition, Inc. Class A Common Stock 13G 6% 2y
Cowen Financial Products LLC LL LL Flooring Holdings, Inc. 13G/A 5.26% 2y
Cowen Financial Products LLC ACET Adicet Bio, Inc. 13G/A 6.29% 2y
COWEN AND COMPANY, LLC CURR Currenc Group Inc. 13G 7.2% 2y
Cowen Financial Products LLC APYX Apyx Medical Corp 13G/A 0% 2y
GOLDMAN SACHS GROUP INC BNL Broadstone Net Lease, Inc. 13G/A 0.2% 2y
COWEN AND COMPANY, LLC GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G 5.5% 2y
Cowen Financial Products LLC GTBIF Green Thumb Industries Inc. 13G/A 0% 2y
COWEN AND COMPANY, LLC FTII FutureTech II Acquisition Corp. 13G 6.8% 2y
GOLDMAN SACHS GROUP INC BLFS Biolife Solutions Inc 13G 5.5% 2y
Cowen Financial Products LLC TRLV Trulieve Cannabis Corp. 13G/A 0% 2y
COWEN AND COMPANY, LLC SLAMF Slam Corp. 13G/A 3.16% 2y
Cowen Financial Products LLC XGN Exagen Inc. 13G/A 5.27% 2y
Stephens Investments Holdings LLC CONN Conn's Inc. 13D/A 9.7% 2y
Aberdeen Group plc SHYF The Shyft Group, Inc. Common Stock 13G/A 0% 2y
180 Degree Capital Corp. SCOR Comscore, Inc. 13D/A 7.2% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 7% 2y
James H. Dahl AXR Amrep Corp. 13D/A 15.8% 2y
FONG GIFFORD PNRG Primeenergy Resources Corp 13D 6.18% 2y
HESTIA CAPITAL PARTNERS LP PBI Pitney Bowes Inc 13D/A 9% 2y
Legion Partners Asset Management, LLC CCO Clear Channel Outdoor Holdings, Inc. 13D/A 5.4% 2y
Saba Capital Management, L.P. ASA ASA Gold & Precious Metals Ltd 13D/A 16.87% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 1.91% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.87% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 19.03% 2y
Brookstone Capital Management AFGR First Trust Exchange-Traded Fund VIII 13G/A 6.08% 2y
Christopher Scott Ginieczki, as Personal Representative of the Estate of Geoffrey S. M. Hedrick IA Innovative Solutions & Support Inc 13D/A 8.58% 2y
GAMCO INVESTORS, INC. ET AL MOD Modine Manufacturing Co 13D/A 3.73% 2y
Constellation Sponsor LP CSTAF Constellation Acquisition Corp I 13D/A 84.7% 2y